As an increasing number of new therapeutics move into clinical trials, a new set of challenges must be met to ensure an effective and integrated product supply. This is especially true for many specialty medicines like orphan drugs, where global distribution coordination is critical to reach a sufficient patient population. Specialized clinical supply services for first-in-human therapeutic validation can be required for the effective management of associated tasks including manufacturing, primary and secondary packaging, kitting, and distribution. These services often now include direct-to-patient supply to facilitate rapid clinical trial results. To learn more, read our executive summary.
Content Type: Whitepaper/Executive Summary
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center